Beam Therapeutics Inc.
BEAMNASDAQHealthcare● Active
$29.52
+$0.12(+0.41%)
Market Cap$3.0B
P/E Ratio—
52W High$36.44
52W Low$15.6
Beam Therapeutics Inc.（BEAM）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · BEAM · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.14B | $0.06B | $0.38B | $0.06B | $0.05B |
| Cost of Revenue | $0.02B | $0.37B | $0.00B | $0.31B | $0.23B |
| Gross Profit | $0.12B | ($0.30B) | $0.38B | ($0.25B) | ($0.18B) |
| Gross Margin %(computed) | 84.05% | -478.67% | 100.00% | -411.48% | -347.75% |
| Operating Expenses | |||||
| R&D Expenses | $0.41B | $0.37B | $0.44B | $0.31B | $0.39B |
| G&A Expenses | $0.11B | $0.11B | $0.12B | $0.09B | $0.06B |
| Total Operating Expenses | $0.50B | $0.11B | $0.55B | $0.09B | $0.21B |
| Operating Income | ($0.38B) | ($0.42B) | ($0.18B) | ($0.34B) | ($0.39B) |
| Operating Margin %(computed) | -274.57% | -654.25% | -46.73% | -555.61% | -757.01% |
| Interest Income | $0.00B | $0.05B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.04B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.08B) | ($0.38B) | ($0.13B) | ($0.29B) | ($0.37B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.08B) | ($0.38B) | ($0.13B) | ($0.29B) | ($0.37B) |
| Net Margin %(computed) | -57.24% | -593.13% | -35.09% | -474.54% | -714.91% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.81 | $-4.58 | $-1.72 | $-4.13 | $-5.77 |
| Wtd Avg Shares | 0.10B | 0.08B | 0.08B | 0.07B | 0.06B |
| EBITDA | ($0.03B) | ($0.39B) | ($0.15B) | ($0.32B) | ($0.23B) |
| EBITDA Margin %(computed) | -21.41% | -619.73% | -38.91% | -532.39% | -443.76% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Beam Therapeutics Inc.
关于Beam Therapeutics Inc.（BEAM）损益表
Beam Therapeutics Inc.（BEAM）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，BEAM实现营收$0.14B，毛利润$0.12B（毛利率84.05%），净利润($0.08B)（净利率-57.24%）。
常见问题
BEAM · 4 问Beam Therapeutics Inc.（BEAM）2025财年营收为$0.14B，同比up120.0%。
BEAM revenueBEAM salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08